Trials / Completed
CompletedNCT04401137
The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects
A Single Center, Randomized, Double Blind, Placebo Controlled, Dose Escalation Clinical Trial to Evaluate Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX After Single Oral Administration in Healthy Korean Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate pharmacokinetic/pharmacodynamic characteristics and safety of QDX after single oral administration in healthy Korean male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topiramate | Topiramate |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-10-06
- Completion
- 2020-10-06
- First posted
- 2020-05-26
- Last updated
- 2020-10-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04401137. Inclusion in this directory is not an endorsement.